Treatment Outcomes in a Centralized Specialty Clinic for Hepatitis C Virus Are Comparable with Those from Clinical Trials
Author(s) -
Kelly Kaita,
Stephen Wong,
Eberhard L. Renner,
Gerald Y. Minuk
Publication year - 2006
Publication title -
canadian journal of gastroenterology
Language(s) - English
Resource type - Journals
eISSN - 1916-7237
pISSN - 0835-7900
DOI - 10.1155/2006/148962
Subject(s) - medicine , ribavirin , hepatitis c , pegylated interferon , clinical trial , hepatitis c virus , specialty , immunology , family medicine , virus
Outcomes from industry-sponsored registration trials are often considered to be more favourable than those achieved in clinical practice because patients involved in the former are highly selected and supported, but it is not known if this impression is valid.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom